These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32736946)

  • 21. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
    Zhu J; Ao H; Liu M; Cao K; Ma J
    J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.
    Cao W; Ni L; Li P; Wang QX; Li MM; Huang SH; Dang NN
    Technol Cancer Res Treat; 2022; 21():15330338221082431. PubMed ID: 35243940
    [No Abstract]   [Full Text] [Related]  

  • 23. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
    Guo X; Li Y; Chen X; Sun B; Guo X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
    Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis.
    Rasouli M; Khakshournia S; Vakili O; Dastghaib S; Seghatoleslam A; Shafiee SM
    Med Oncol; 2023 Jun; 40(7):199. PubMed ID: 37294480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5.
    Wang L; Tang L; Xu R; Ma J; Tian K; Liu Y; Lu Y; Wu Z; Zhu X
    Cell Death Dis; 2021 Jul; 12(8):753. PubMed ID: 34330893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCF-FBXL8 contributes to liver metastasis and stem-cell-like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53.
    Yao J; Wang XP; Yang J; Yang Z; Zhang ZY
    Clin Transl Med; 2023 Mar; 13(3):e1208. PubMed ID: 36855778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress.
    Jiang X; Ma Y; Wang T; Zhou H; Wang K; Shi W; Qin L; Guan J; Li L; Long B; Wang J; Guan X; Ye H; Yang J; Yu Z; Jiao Z
    Gastroenterology; 2023 Jun; 164(7):1232-1247. PubMed ID: 36842710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
    Wen M; Kwon Y; Wang Y; Mao JH; Wei G
    Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
    Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
    J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis.
    Cai F; Xu H; Song S; Wang G; Zhang Y; Qian J; Xu L
    Curr Protein Pept Sci; 2024; 25(7):577-585. PubMed ID: 38584528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
    Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
    Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
    Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
    Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
    Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
    Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination.
    Yu Z; Jiang X; Qin L; Deng H; Wang J; Ren W; Li H; Zhao L; Liu H; Yan H; Shi W; Wang Q; Luo C; Long B; Zhou H; Sun H; Jiao Z
    Oncogene; 2021 Feb; 40(5):1027-1042. PubMed ID: 33323973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
    Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
    Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.